Efficacy of Genicular Nerve Alcohol Neurolysis in Knee Osteoarthritis Pain
CompletedNCT06060678
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aimed to evaluate the efficacy of genicular nerve alcohol neurolysis in the treatment of pain caused by chronic knee osteoarthritis. The investigators will evaluate the efficacy of genicular nerve alcohol neurolysis using the numeric rating scale (NRS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). NRS and WOMAC scores will be evaluated before, 1, and 3 months after the procedure.
Study details
- Official title
- Evaluation of the Efficacy of Genicular Nerve Alcohol Neurolysis in the Management of Knee Osteoarthritis Pain
- Conditions
- Sponsor
- Diskapi Teaching and Research Hospital
- Start date
- 2023-05-09
- Primary completion
- 2023-11-01
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Moderate to severe knee pain due to knee osteoarthritis (0-10 pain of intensity 6 and above on an inter-numeric pain scale) * Permanent pain for more than 6 months * Grade 3 or 4 in the radiological Kellgren-Lawrence classification having osteoarthritis * Pain with conservative methods such as analgesics and physiotherapy treatment failure Exclusion Criteria: * History of intra-articular knee intervention in the last 6 months * Cognitive impairment * Hepatic or renal insufficiency * Severe psychiatric illness * Local or systemic infection * Coagulopathy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06060678